Balloon REmodeling Antrostomy THErapy Study (BREATHE I)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00645762
Recruitment Status : Completed
First Posted : March 28, 2008
Results First Posted : July 29, 2013
Last Update Posted : July 29, 2013
Information provided by (Responsible Party):
Entellus Medical, Inc.

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment;   Masking: None (Open Label);   Primary Purpose: Treatment
Condition: Sinusitis
Interventions: Device: RS-Series Rhinosinusitis Treatment System
Device: FinESS Balloon

  Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
Enrolled patients with chronic rhinosinusitis (CRS) from Ear, Nose Throat (ENT) physician practices.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
All patients had transantral balloon dilation of the maxillary sinus ostium and ethmoid infundibulum with the FinESS Sinus System.

Reporting Groups
FinESS Sisnus System Balloon Dilation Transantral balloon dilation ofthe maxillary sinuses with the FinESS Sinus System.

Participant Flow:   Overall Study
    FinESS Sisnus System Balloon Dilation

  Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
Balloon Dilation No text entered.

Baseline Measures
   Balloon Dilation 
Overall Participants Analyzed 
[Units: Participants]
[Units: Years]
Mean (Standard Deviation)
 47.3  (13.7) 
[Units: Participants]
Female   45 
Male   26 
Region of Enrollment 
[Units: Participants]
United States   71 

  Outcome Measures

1.  Primary:   Incidences of Device-related or Procedure-related Complications   [ Time Frame: Through 12 months post-procedure ]

2.  Primary:   Patency of the Treated Area as Verified by CT Scan   [ Time Frame: Post-treatment at 3 months ]

3.  Primary:   Symptomatic Score Change- Sinonasal Outcome (SNOT) 20 Score Improvement   [ Time Frame: Post-treatment through 12 months ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

  More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
The agreement is:
unchecked The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
unchecked Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.

Results Point of Contact:  
Name/Title: Entellus Medical
Organization: Entellus Medical
phone: 763-463-1599

Publications automatically indexed to this study by Identifier (NCT Number):

Responsible Party: Entellus Medical, Inc. Identifier: NCT00645762     History of Changes
Other Study ID Numbers: 1156-001
First Submitted: March 20, 2008
First Posted: March 28, 2008
Results First Submitted: March 15, 2013
Results First Posted: July 29, 2013
Last Update Posted: July 29, 2013